INTRODUCTION
Glycosylphosphatidylinositol (GPI) membrane anchors are found on many eukaryotic cell-surface glycoproteins, and their structures, functions and biosynthesis have been extensively reviewed [1] [2] [3] [4] [5] [6] . The minimum GPI-anchor structure is NH # CH # CH # -HPO % -6Manα1-2Manα1-6Manα1-4GlcNα1-6-myo-inositol-1-HPO % -lipid (EtNP-Man $ GlcN-PI), where the lipid may be diacylglycerol, alkylacylglycerol or ceramide [1] .
Proteins destined to be GPI-anchored are attached to the amino group of the terminal ethanolamine phosphate (EtNP) residue by a transamidation reaction whereby a hydrophobic Cterminal peptide is exchanged for a preassembled GPI precursor in the endoplasmic reticulum [5] . The minimum GPI-anchor structure described above is highly conserved but it may be modified with additional ethanolamine phosphate groups and with carbohydrate side chains in a species-and tissue-specific manner [1] .
The biosynthesis of GPI anchors involves the addition of GlcNAc to phosphatidylinositol (PI), to give GlcNAc-PI, which is de-N-acetylated to form GlcN-PI [6] [7] [8] [9] . A Chinese hamster ovary cell mutant that is deficient in GlcNAc-PI de-N-acetylase activity has been described recently [10] but the defective gene has yet to be isolated. De-N-acetylation is a prerequisite for the mannosylation of GlcN-PI to form later GPI intermediates [11] and it has been suggested that this step is regulated in mammalian cells by GTP [9] .
The GlcNAc-PI de-N-acetylase of Trypanosoma brucei has been partially purified and characterized [12] using a series of GlcNAc-PI analogues [13] to assess the importance of the fatty Abbreviations used : AHM, 2,5-anydromannitol ; GPI, glycosylphosphatidylinositol ; Pl, phosphatidylinositol ; Pl-PLC, phosphatidylinositol-specific phospholipase C ; GPI-PLD, glycosylphosphatidylinositol-specific phospholipase D ; Pr, propionyl ; Bu, butyryl ; iBu, isobutyryl ; Pen, pentanoyl ; Hex, hexanoyl ; JBAM, jack-bean α-mannosidase ; GC, gas chromatography. 1 To whom correspondence should be addressed.
GlcNR-PI substrates, where R l acetyl (Ac), propionyl (Pr), butyryl (Bu), isobutyryl (iBu), pentanoyl (Pen) or hexanoyl (Hex). The data show that the trypanosomal and HeLa enzymes had similar specificities and that the turnover of GlcNR-PIs by the trypanosomal enzyme was in the order GlcNAc-PI GlcNPr-PI GlcNBu-PI $ GlcNiBu-PI $ GlcNPen-PI GlcNHex-PI. The trypanosome and HeLa de-N-acetylases were unable to de-N-acetylate mannosylated GlcNAc-PI intermediates, which explains why de-N-acetylation must precede mannosylation in the GPI biosynthetic pathway.
acids and glycerophosphate components and the absolute configuration of the myo-inositol residue for substrate recognition. The study concluded that : (i) the fatty acids assist in the presentation of the substrate to the enzyme, but are not essential for substrate recognition ; (ii) a phosphodiester linkage between the myo-inositol and glycerol residues is essential for substrate recognition ; (iii) -myo-inositol can be replaced by -myo-inositol without loss of substrate recognition ; (iv) product inhibition by GlcN-PI and acetate is negligible.
In the present study, we report the substrate specificity of T. brucei and human (HeLa cell) GlcNAc-PI de-N-acetylases with respect to the size of the N-acyl (R) group that can be cleaved from a series of GlcNR-PI substrates. We also assess the ability of these enzymes to de-N-acetylate mannosylated GlcNAc-PI intermediates.
MATERIALS AND METHODS

Materials
GDP-[1-$H]Man (15n0 Ci\mmol), [9,10-$H]myristic acid (11n2 Ci\mmol) and En$Hance4 were purchased from Du Pont-NEN, and jack-bean α-mannosidase (JBAM) was from Boehringer-Mannheim. Bacillus thuringiensis phosphatidylinositolspecific phospholipase C (PI-PLC) was a gift from Dr. M. Low, Columbia University, New York, NY, U.S.A. Whole human serum was used as a source of GPI-specific phospholipase D (GPI-PLD). Ion-exchange resins (AG-50X12 and AG-3X4) were obtained from Bio-Rad, and all the other reagents were purchased from Sigma.
Preparation of trypanosomes and the trypanosome cell-free system
Bloodstream forms of T. brucei (variant MITat1.4) were isolated from infected rats and mice. Trypanosome membranes (trypanosome cell-free system) were prepared as previously described by Masterson et al. [14] , except that the cells were not preincubated with tunicamycin before lysis.
Preparation of HeLa cells and the HeLa cell-free system
HeLa cells were grown at 37 mC in Dulbecco's modified minimal essential medium supplemented with 10 % fetal calf serum in a 5 % CO # atmosphere. The HeLa cell-free system was prepared as described by Gu$ ther et al. [15] , except that subconfluent HeLa cells were treated with 5µg\ml tunicamycin for 2 h at 37 mC and then incubated for 10 min at 37 mC with PBS containing 0n5 mM EDTA (instead of trypsin). The cells were washed twice with 30 ml of PBS to remove EDTA and were then hypotonically lysed in water containing 0n1 mM Tos-Lys-CH # Cl and 0n1 µg\ml leupeptin. An equal volume of 100 mM Hepes\NaOH buffer, pH 7n4, containing 50 mM KCl, 10 mM MgCl # , 0n1 mM TosLys-CH # Cl, 0n1 µg\ml leupeptin and 20 % (w\v) glycerol was added to the lysate. Aliquots containing either 10( or 2i10( cell equivalents\ml were stored at k70 mC. The procedure used was similar to that described by Milne et al. [8] . Trypanosomes (variant MITat 1n4) from the buffy coat of infected rat blood were washed and suspended at 5i10( cells\ml in complete RPMI 1640 medium (Gibco) buffered with 25 mM Hepes\NaOH, pH 7n4, and supplemented with 2 mg\ml BSA (fatty acid-free). The cells were preincubated with 0n8 mM PMSF for 15 min at 37 mC.
Preparation of semisynthetic
[$H]Myristic acid complexed to BSA (1 mol\mol) was added in RPMI 1640 medium to give a final concentration of 50 µCi\ml. After 30 min at 37 mC, the trypanosomes were pelleted and extracted with chloroform\methanol\ water (10 : 10 : 3, by vol.) at 2n5i10) cells\ml with vortex-mixing and sonication. After centrifugation, the supernatants were evaporated to dryness in a stream of nitrogen and the products were partitioned between 200 µl of butan-1-ol and 200 µl of water. After vortex-mixing and centrifugation the radiolabelled glycolipids were recovered in the upper butan-1-ol phase which was concentrated to dryness in a SpeedVac evaporator, and the residue was subjected to high-performance TLC (HPTLC). Man $ GlcN-PI labelled with [$H]myristate in the lipid moiety, which accumulates in the presence of PMSF [16] , was located on the HPTLC plate using a Raytest RITA linear analyser (LabLogic, Sheffield, Yorkshire, U.K.). The excised silica was extracted with methanol\pyridine\water 
Synthetic GlcNR-PI substrates
-GlcNα1-6-myo-inositol-1-HPO % -(sn-1,2-dipalmitoyglycerol) (GlcN-PI) was synthesized as described by Cottaz et al. [17] and was N-acylated at 0 mC in 100 µl of saturated NaHCO $ by the addition of three aliquots (2n5 µl) of the appropriate acid anhydride (acetic, propionic, butyric, isobutyric, pentanoic or hexanoic anhydride) at 10 min intervals. The reaction mixture was allowed to warm to room temperature and the N-acylated glycolipids were isolated and desalted by extraction into butan-1-ol. The butan-1-ol phases were evaporated to dryness, the residues were dissolved in 20 % propan-1-ol\10 mM ammonium acetate (solvent A) and the resulting solutions were applied to a reverse-phase HPLC column (Kromasil 5 µ C8 ; 25 cmi 0n46 mm) equilibrated with the same solvent. The column was eluted first with solvent A for 10 min, then with a linear gradient to 50 % propan-1-ol\10 mM ammonium acetate over 20 min and finally with a linear gradient to 90 % propan-1-ol\10 mM ammonium acetate over 120 min with a flow rate of 0n5 ml\min throughout. The GlcNR-PI products were eluted at about 70 % propan-1-ol.
The authenticity and purity of the synthetic N-acylated compounds was checked by negative-ion electrospray MS. The concentrations of solutions containing GlcNR-PIs were measured by analysing the myo-inositol content by gas chromatography (GC)-MS, as described below.
Trypanosome de-N-acetylase assays using [ 3 H]myristate-labelled GlcNR-[ 3 H]PIs and Man 1 GlcNAc-[ 3 H]PI
The trypanosome cell-free system was used as the source of GlcNAc-PI de-N-acetylase. Trypanosome membranes were washed twice in 0n1 M Hepes buffer, pH 7n4, containing 25 mM KCl, 5 mM MgCl # , 0n1 mM Tos-Lys-CH # Cl and 2 µg\ml leupeptin, and were then suspended at 5i10) cell equivalents\ml in incorporation buffer : 50 mM Hepes, pH 7n4, 25 mM KCl, 5 mM MgCl # , 5 mM MnCl # , 10% (v\v) glycerol, 1n25 µg\ml tunicamycin, 0n1 mM Tos-Lys-CH # Cl, 1 µg\ml leupeptin, 10 mM Nethylmaleimide and 10 mM (0n3 %, w\v) n-octyl β--glucopyranoside. Aliquots (50 µl) of this lysate were added to tubes containing dry [$H]myristate-labelled GlcNR-[$H]PI (5000 c.p.m.), vortex-mixed and incubated at 35 mC for 16 h. The reactions were terminated by the addition of 333 µl of chloroform\methanol (1 : 1, v\v). The glycolipid products were recovered in the chloroform\methanol\water-soluble fraction, which was evaporated to dryness and the residue was partitioned between butan-1-ol and water, as described by Gu$ ther et al. [15] . The butan-1-ol phases containing the glycolipids were analysed by HPTLC.
HeLa cell de-N-acetylase assays on [ 3 H]myristate-labelled GlcNR-[ 3 H]PIs and Man 1 GlcNAc-[ 3 H]PI
HeLa cell lysate aliquots of 1 ml (2i10( cell equivalents) were thawed and supplemented with 0n5 mM dithiothreitol, 0n2 µg\ml 1, v\v) . The glycolipid products were recovered as described above and analysed by HPTLC.
Trypanosome de-N-acylation/[ 3 H]mannosylation assay
Aliquots (50 µl) of washed trypanosome membranes suspended in incorporation buffer were added to tubes containing dry GDP-[$H]Man (0n5 µCi) and 365 pmol of synthetic GlcNR-PI substrate and were then incubated at 30 mC for 1 h. The reactions were terminated by the addition of 333 µl of chloroform\ methanol (1 : 1, v\v). The glycolipid products were recovered as described above and analysed by HPTLC both before and after enzymic and chemical treatments (see below).
HeLa cell de-N-acylation/[ 3 H]mannosylation assay
HeLa cell lysate was thawed and supplemented as described above and, unless otherwise indicated, 1 mM CoA and 10 mM ATP were added to the lysates. Aliquots (100 µl) of the lysate were added to tubes containing dry GDP-[$H]Man (2n5 µCi) and 1400 pmol of synthetic GlcNR-PI substrate and were then incubated at 37 mC for 1n5 h. The reactions were terminated by the addition of 666 µl of chloroform\methanol (1 : 1, v\v). The glycolipid products were recovered as described above and analysed by HPTLC both before and after enzymic and chemical treatments. The major radiolabelled glycolipid formed in the assay was purified by preparative HPTLC and then subjected to chemical modification and glycan analysis as described below.
Enzymic and chemical treatments of radiolabelled glycolipids
Digestion of the glycolipid extracts with the enzymes JBAM, PI-PLC and GPI-PLD and subsequent product analysis by HPTLC was carried out as described previously [15] . HNO # deamination of the glycolipids was performed in 20 µl of 0n1 M sodium acetate, pH 4n0, containing 0n01 % Zwittergent 3-16. Aliquots (10 µl) of freshly prepared 0n5 M NaNO # were added at hourly intervals during incubation at 60 mC for 4 h. The products of deamination were recovered for HPTLC analysis by extraction into butan-1-ol.
HPTLC
Samples and glycolipid standards were applied to 10 or 20 cm aluminium-backed silica gel 60 HPTLC plates (Merck) which were developed in chloroform\methanol\1 M ammonium acetate\13 M ammonium hydroxide\water (180 : 140 : 9 : 9 : 23, by vol.). Radiolabelled components were detected using a phosphorimager (see below) and\or, after spraying with En$Hance4, by fluorography at k70 mC using Kodak XAR-5 film and an intensifying screen.
Phosphorimager quantification of [ 3 H]mannosylated glycolipids on HPTLC plates
To quantify the relative amounts of radioactivity in particular glycolipid bands, some of the HPTLC plates were exposed to tritium screens which were subsequently analysed in a Molecular Dynamics phosphorimager. The relative amounts of substrate de-N-acylation in the de-N-acylation\[$H]mannosylation assays were estimated by integrating the phosphorimager signals corresponding to the exogenous H5 band (for the HeLa cell assay ; Figure 6 ) or corresponding to the Man " GlcN-PI to glycolipid A region (for the trypanosome assay ; Figure 2 ).
Inositol analysis
GC-MS (Hewlett Packard 5970-MSD) was used to measure the myo-inositol content of the synthetic GlcNR-Pls. Aliquots of the compounds were mixed with 50 pmol of the internal standard [1,2,3,4,5,6-#H]myo-inositol and treated with 50 µl of 6 M HCl at 110 mC for 16-18 h. After removal of the acid by evaporation, the products were converted into their trimethylsilyl derivatives for analysis by GC-MS, as described by Ferguson [18] .
Electrospray MS
A Micromass Quattro spectrometer was used to acquire negativeion electrospray mass spectra over the range m\z 150-1150. Samples (5-20 µl at approx. 20 pmol\µl) were introduced into the ion source in aq. 50 % acetonitrile at a flow rate of 10 µl\min. Scans were averaged and processed using MassLynx software.
Glycan head-group analysis of the major radiolabelled glycolipid generated in the HeLa cell-free system
The major product labelled with GDP-[$H]Man in the presence of synthetic GlcNAc-PI in the HeLa cell-free system (designated as H5 in Figure 5 ) was purified by HPTLC as described above. The glycolipid was delipidated by base hydrolysis [100 µl of conc. ammonia\methanol (1 : 1, v\v), 50 mC for 6 h], dried, dissolved in 50 µl of 0n1 M sodium acetate, pH 4n0, and treated with 50 µl of freshly prepared 0n5 M NaNO # for 2n5 h at room temperature. Subsequent NaB#H % reduction was performed by the addition of 25 µl of 0n8 M boric acid and transfer of the mixture into 50 µl of 0n1 M NaOH containing 1 M NaB#H % with incubation for 16 h at room temperature. The reaction mixture was acidified with acetic acid and desalted by passage through AG50X12(H + ), drying and removal of boric acid and acetic acid by coevaporation with methanol and toluene respectively. The product so obtained was dephosphorylated with 50 µl of aq. 48 % HF (0 mC for 48 h) ; saturated LiOH was used to neutralize the acid, which precipitated as LiF [18] . The supernatant containing the deaminated, reduced and dephosphorylated neutral glycan fraction was desalted by passage through a tandem column of ion-exchange resins [AG50X12(H + ) over AG3X4(OH − )].
Glycan analysis
The neutral glycan fraction obtained from the above procedure was filtered through a 0n2 µm membrane and analysed by BioGel P4 gel filtration using an Oxford Glycosystems GlycoMap. Fractions (330 µl) were collected and counted for radioactivity. GlcN-PI [16] , arising from the inhibition of inositol acylation [15] and the subsequent addition of ethanolamine phosphate [19] . The Man $ GlcN-PI intermediate that accumulates in the cells undergoes fatty acid remodelling with the introduction of [$H]myristate into the PI moiety [15] . This intermediate was purified by HPTLC and then digested with The specificity of the GlcNAc-PI de-N-acetylase for the N-acyl group was also investigated using an indirect assay based on the ability of chemically synthesized (non-radiolabelled) GlcNR-PI substrates to undergo mannosylation by the trypanosome cellfree system. Previous studies showed that de-N-acetylation of exogenous GlcNAc-PI precedes the addition of the three αMan residues in the GPI biosynthetic pathway [11] so that mannosylation of exogenous substrates can be used as an indirect (but highly sensitive) measure of GlcNR-PI de-N-acylation.
RESULTS AND DISCUSSION
Specificity of the trypanosome GlcNAc-PI de-N-acetylase for the N-acyl moiety
GlcN-PI, synthesized as described by Cottaz et al. [17] , was Nacylated with the appropriate anhydride, and the N-acylated products were purified by reverse-phase HPLC. The purified Nacylated compounds (including the N-pentanoyl and N-hexanoyl derivatives GlcNPen-PI and GlcNHex-PI) were analysed by negative-ion ES-MS, which showed that all of the preparations were pure, and quantified by GC-MS measurement of the myoinositol content.
The assay shown in Figure 2 reveals that, in the absence of an exogenous substrate, the cell-free system labelled with GDP-[$H]Man produces Dol-P-[$H]Man (the immediate donor for α-mannosyltransferases of the GPI pathway [20] ) and low levels of labelled endogenous GPI intermediates ( Figure 2, lane 2) . The addition of synthetic GlcN-PI (the natural acceptor substrate for the first α-mannosyltransferase of the GPI pathway) leads to the formation of additional GPI intermediates (Figure 2, lane 3) which migrate fractionally more slowly than the endogenous GPI species. This is presumably due to shorter acyl chains being attached to the glycerol backbone in synthetic GlcN-(sn-1,2-diplamitoyl)PI compared with those of endogenous intermediates [21] . As noted previously, the addition of GlcNAc-PI produces substantially more mannosylated GPI intermediates than does the addition of GlcN-PI (compare Figure 2, lanes 3 and 4) , suggesting that GlcN-PI is best presented to the α-mannosyltransferases via the de-N-acetylase [11] . The compounds GlcNPr-PI, GlcNBu-PI, GlcNiBu-PI and GlcNPen-PI were also able to undergo de-N-acylation and subsequent mannosylation ( Figure  2 , lanes 5-8), whereas GlcNHex-PI showed no detectable de-Nacylation\mannosylation activity (Figure 2, lane 9) . The relative order of substrate processing was GlcNAc-PI GlcNPr-PI GlcNiBu-PI $ GlcNBu-PI $ GlcNPen-PI. The mannosylated GPI intermediates portrayed in lanes 3-8 were sensitive to both PI-PLC [except for Man $ GlcN(acyl)PI which is inherently PI-PLC resistant] and HNO # , confirming their identities as de-Nacylated GPI intermediates (results not shown).
Taken together, the two assays employed above show that the relative rate of de-N-acylation of GlcNR-PI decreases with increasing size of the N-acyl group. There is one slight discrepancy between the two assays ; GlcNBu-[$H]PI appears to be turned over more efficiently than GlcNiBu-[$H]PI (Figure 1 ) whereas GlcNBu-PI and GlcNiBu-PI gave similar results in the de-Nacetylation\[$H]mannosylation assay (Figure 2) . The reason for this discrepancy is not clear, but it may reflect the fact that the substrates are presented to the membranes at a much lower final concentration when radiolabelled GlcNR-[$H]PI substrates are used. However, it can be concluded that both the N-butyryl and N-isobutyryl derivatives are relatively poor substrates whereas the N-propionyl derivative is a relatively good substrate when compared with the natural N-acetyl substrate. 
The presence of mannose residues prevents de-N-acetylation of GlcNAc-PI by the trypanosome cell-free system
